Publications by authors named "I Poole"

Vitiligo has a complex multifactorial etiology involving a T-cell mediated autoimmune response to cutaneous melanocytes. Microbial dysbiosis has been assigned a contributing role in vitiligo etiology. Treating vitiligo can be a challenging task and finding novel treatment approaches is crucial.

View Article and Find Full Text PDF
Article Synopsis
  • Exposure to nitrogen mustard, a type of chemotherapy, causes skin damage and inflammation due to the recruitment of immune cells that worsen the injury and hinder healing.
  • Administering poly(lactic-co-glycolic acid) immune-modifying nanoparticles (PLGA-IMPs) right after exposure can reduce harmful immune cell accumulation in the skin and improve healing outcomes.
  • PLGA-IMPs promote the presence of regulatory T cells that help control inflammation by producing key anti-inflammatory cytokines, suggesting a potential treatment strategy for severe skin injuries.
View Article and Find Full Text PDF

Apoptotic melanocytes (MCs) may release neoantigenic epitopes preceding epidermal infiltration by autoreactive CD8 T cells in early vitiligo. However, the mechanism by which vitiligo MCs are prone to apoptosis under oxidative stress remains elusive. Pro-apoptotic receptor C-X-C motif chemokine receptor 3 isoform B (CXCR3B) is critical for inducing MC apoptosis in the inflammatory microenvironment of lesional vitiligo skin.

View Article and Find Full Text PDF

Juvenile Dermatomyositis (JDM) is the most common inflammatory myopathy in pediatrics. This study evaluates the role of Natural Killer (NK) cells in Juvenile Dermatomyositis (JDM) pathophysiology. The study included 133 untreated JDM children with an NK cell count evaluation before treatment.

View Article and Find Full Text PDF

The autoimmune condition vitiligo, characterized by skin depigmentation, presents challenges for effective treatment design, with Janus kinase (JAK) inhibitors and other repurposed drugs offering a promising strategy for symptom management. This review explores advantages and shortcomings of current therapies, while presenting the urgent need for further innovative approaches. We emphasize the growing understanding of autoimmune involvement in vitiligo, highlighting several novel treatment avenues including relieving melanocyte stress, preventing dendritic cell activation, halting T cell migration, and suppressing inflammation and autoimmunity.

View Article and Find Full Text PDF